Arginase II activity regulates cytosolic Ca2+ level in a p32-dependent manner that contributes to Ca2+-dependent vasoconstriction in native low-density lipoprotein-stimulated vascular smooth muscle cellsBon‐Hyeock Koo, Sungwoo Ryoo|Experimental & Molecular Medicine|2019Cited by 33
Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cellsBon‐Hyeock Koo, Sungwoo Ryoo|Cardiovascular Research|2021Cited by 18
Arginase II inhibition prevents interleukin-8 production through regulation of p38 MAPK phosphorylation activated by loss of mitochondrial membrane potential in nLDL-stimulated hAoSMCsBon‐Hyeock Koo, Sungwoo Ryoo|Experimental & Molecular Medicine|2018Cited by 17
Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca<sup>2+</sup>-dependent eNOS activationBon‐Hyeock Koo, Sungwoo Ryoo|BMB Reports|2021Cited by 15
NADPH oxidase activation contributes to native low-density lipoprotein-induced proliferation of human aortic smooth muscle cellsIl Hwan Park, Sungwoo Ryoo|Experimental & Molecular Medicine|2015Cited by 13